Oral Biologics: Nwere ike Mgbanwe Peptide mechie oghere nnyefe?

Ihe mgbochi nnyefe ọnụ - nkenke na nke akọwapụtara

peptides anaghị agbanwe agbanwe ewepụtara ọnụ na-eche mfu anọ n'usoro tupu ha erute n'usoro: acid-mediated hydrolysis na afo, mmebi nke protease n'ime obere eriri afọ (serine, cysteine, na ezinụlọ metalloprotease), adịghị ike nke mucosal na-ebute site na ịdị arọ molekụla, polarity, na ụgwọ, na mkpochapụ imeju afọ nke mbụ. The Frontiers Drug Delivery pharmacokinetic analysis bipụtara na 2026 na-etinye bioavailability ọnụ maka ọtụtụ peptides ọgwụgwọ anaghị agbanwe agbanwe n'okpuru 1-2% ọbụlagodi n'ọnọdụ nhazi kachasị mma., N'izo aka nchikota mmetụta nke mfu anọ a.

Ọ dịghị atụmatụ mgbanwe na-ewepụ ihe mgbochi anọ niile n'otu oge. Atụmatụ ọ bụla na-elekwasị anya adịghị ike dị iche, na ndị na-aga ime ọnụ na-ejikọta ihe karịrị otu. Ihe klaasị mgbanwe na-ekekọrịta bụ nke a: onye ọ bụla na-agbanwekwa omume nyocha nke molekul ahụ n'ụzọ a ga-ebu ụzọ lebara ya anya tupu enwere ike ịtụkwasị data GI pharmacokinetic obi..

Cyclization — Conformational mkpọchi na ihe ọ chọrọ gị nyocha

Peptide Synthesis Cyclization na-eme ka nkwụsi ike nke peptide ọnụ bụ isi site na iwepu N- na C-termini nke exopeptidases na-amata dị ka ebe ntinye nkwụsị. A 2017 Nyocha nyocha nke ACS nke peptides cyclic na-etinye ọnụ n'ọnụ gosiri na iwepụ ndị a termini - site isi-na-ọdụ amide bond, disulfide àkwà mmiri, nnukwu macrocycles, ma ọ bụ njikọ njikọ lactam - na-abawanye iguzogide mmebi na mmiri gastric na eriri afọ.. Mmetụta mmetụta mgbe cyclization jikọtara na N-methylation nke amide bonds, nke na-ebelata ọnụ ọgụgụ ndị na-enye onyinye hydrogen ma na-emeziwanye ike nke akpụkpọ ahụ na-agafe agafe maka ụmụ irighiri ihe na-enweghị ike iji ụgbọ njem na-arụ ọrụ..

Nkwenye ụlọ ọgwụ dị ugbu a bara nnukwu uru. Octreotide (Mycapssa) bụ peptide cyclic disulfide-bridged nke rutere n'ahịa dị ka usoro ọnụ maka acromegaly.. Cyclosporine A na voclosporin bụ immunosuppressants cyclized isi na ọdụ nwere bioavailability ọnụ edepụtara.. Na nso nso a, mmemme peptide cyclic nke Chugai LUNA18 kọrọ banyere bioavailability ọnụ nke 21-47% n'ofe anụmanụ anọ, nsoro enweghị ike iru ya na scaffold linear.

Kedu ihe nyocha gị kwesịrị ijikwa: peptides cyclic na-emepụta ụkpụrụ nkewa n'ụdị na LC-MS/MS ma e jiri ya tụnyere ndị ogbo ha.. The scaffold siri ike nwere ike iwepụta iberibe isi mmalite ma ọ bụ ọtụtụ ụdị ụgwọ steeti na-eme ka nhọrọ mgbanwe MRM sie ike.. Karia nka, a 2025 Nyocha PMC nke ihe mgbochi na atụmatụ peptide ọnụ na-ekwu na cyclization anaghị egbochi kpamkpam mmebi GI - ọ na-ebelata ya - nke pụtara peptide cyclic na-emebibeghị yana ụdị mgbanaka mepere emepe ma ọ bụ nke nwere akụkụ hydrolyzed nwere ike jikọta ya na nlele GI matrix.. A ghaghị igosipụta nhọrọ nke assay megide ngwaahịa mmebi iwu ndị a, ọ bụghị naanị megide ndabere matrix endogenous.

Omenala njikọ nke peptide cyclic N'ọ̀tụ̀tụ̀ nyocha chọrọ ka kemịkalụ cyclization dabara na mkpa njiri mara ala nke onye nyocha.. Ịgba ígwè nke disulfide, nnukwu macrocycles, na mgbanaka lactam-bridged nke ọ bụla na-enye ihe nchebe dị iche iche chọrọ n'oge SPPS na profaịlụ kwụsiri ike dị iche iche na nhazi na nchekwa nke ọrụ bioanalytical..

Lipidation - Albumin na-ejikọta, Ụgbọ njem GI, na Metabolite Complexity

Lipidation na-ejikọta acid fatty - nke kachasị C14, C16, ma ọ bụ C18 - ruo n'azụ peptide site na amide kwụsiri ike, ester, ma ọ bụ thioether bond, mgbe ụfọdụ site a bifunctional linker. Uru izizi ọgwụ na-erite uru bụ njikọta nke serum albumin. Albumin na-arụ ọrụ dị ka ebe nchekwa na-ekesa na-echebe peptide site na renal filtration na mkpochapụ enzymatic ma na-agbatị ọkara ndụ plasma nke ukwuu.. Maka mmemme ọnụ, lipidation na-enye uru ọzọ: Mkpakọrịta akpụkpọ ahụ na-abawanye na epithelium eriri afọ nwere ike ịkwalite nnabata transcellular n'okpuru ọnọdụ ụfọdụ.

A na-eji usoro ahụ eme ihe na-ahụ maka ụlọ ọgwụ na semaglutide (Ịkụ azụ̀), nke na-agụnye C18 fatty diacid nke agbakwunyere site na mini-PEG linker iji jigide njikọ albumin dị elu ma na-enye ohere nnyefe ọnụ na sistemu nnabata SNAC.. Ihe analog nke GLP-1 MEDI7219, mepụtara na AstraZeneca, were ụzọ yiri ya: a 2025 PMC metabolite nchọpụta nchọpụta kọrọ na ihe dị ka 60% nke MEDI7219 nọgidere na-emebibeghị mgbe 2 awa nke in vitro incubation na ọnọdụ GI emepụtara, Ọ ka mma karịa GLP-1 na-agbanweghị agbanwe ma ọ bụ semaglutide n'okpuru otu ọnọdụ.

Dị ka Nlebanya PMC zuru oke nke atụmatụ lipidation peptide (2023) na-achikota, mkpado lipid na-emetụta ọ bụghị naanị ọkara ndụ kamakwa usoro nke abụọ, mmekọrịta akpụkpọ anụ, na njikọ njikọ anabatara n'ụzọ ndị a ga-eji mara maka molekul ọ bụla akọwapụtara. Mmụba lipophilicity na-emetụtakwa ka akụkụ nke molekul n'oge mmịpụta sample, nke nwere nsonaazụ nyocha ozugbo.

Kedu ihe nyocha gị kwesịrị ijikwa: peptides lipidated na-egosipụta njikọ siri ike na-enweghị nkọwa na ngwa plastik, kọlụm frits, na autosampler components na obere mkpokọta. Nke a bụ isi mmalite nke ebu-site na njehie nhazi n'ime ọmụmụ PK nnyefe ọnụ, ebe mkpokọta peptide nne na nna ka emechara ọgwụ adịlarị ala. Ụzọ metabolic sitere na peptide lipidated na-agụnyekarị deacylation (mwepụ nke fatty acid), β-oxidation ngwaahịa, na peptide n'ọkpụkpụ azụ nke mgbawa - nke niile nwere ike ịmepụta ụdị nwere ntughari uka na-agafe agafe.. A 2024 Nyocha IQVIA/PMC nke nnyonye anya mgbaàmà na LC-ESI-MS kwadoro na nnyonye anya n'ime ionization dị n'etiti ọgwụ na ụdị metabolite nwere ike ibelata mgbaàmà nyocha a tụrụ atụ site na ihe zuru ezu iji gbagọọ atụmatụ paramita PK.. A na-achọkarị calibrators matriks dakọtara na njiri mara metabolite siri ike site na HRMS tupu enwee ike ntụkwasị obi dabere na MRM..

Stapling, Njikọta, na Atụmatụ Mgbochi Ọdịdị

Peptides stapled na GI kwụsie ike

Peptide stapling na-ewebata akwa mmiri niile-hydrocarbon dị n'etiti ihe abụọ - nke na-abụkarị m na i + 4 - nke na-akpọchi peptide n'ime nhazi alfa-helical.. Nkwụsi ike nke na-esi na ya pụta na-eme ka nguzogide protease dịkwuo mma site n'igosi geometry mkpụrụ nke ọtụtụ GI proteases na-ejikwa nke ọma nke ọma karịa yinye linear na-agbanwe agbanwe.. Ebumnuche ebumnuche bụ isi bụ mgbochi mmekọrịta protein-protein intracellular - klaasị ebumnuche enweghị ike ịnweta obere ụmụ irighiri ihe na-esikwa ike maka mgbochi mgbochi itinye aka - mana edepụtala ndozi nkwụsi ike GI n'ofe ọtụtụ scaffolds..

Nke 2015 ACS Molecular Pharmaceutics ọmụmụ na GI kwụsie ike nke 17 ọgwụ peptide nyochaa kpọmkwem otú dị iche iche mgbanwe atụmatụ, gụnyere peptide stapling etinyere na salmon calcitonin analogs, agbanweela nguzogide nbibi nke enzymatic na ụdị mmiri gastric na eriri afọ. Ihe omuma a gosiputara nkwalite nkwụsi ike enwere ike itule, ọ bụ ezie na nkwalite ahụ adịchaghị agbanwe agbanwe karịa maka ịgbagharị n'ofe peptide a nyochara.

Ihe peptides nke stapled chọrọ kemịkalụ sịntetik kpọmkwem - na-abụkarị metathesis na-emechi mgbanaka (RCM) N'okpuru ọnọdụ dakọtara na usoro zuru oke - yana nsonaazụ mmachi nwere ike iwepụta ọtụtụ iberibe n'ụdị n'oge nyocha nkwụsi ike in vitro GI yana nyocha nlele vivo.. Nbibi n'ime isi iyi iji mepụta ion ngwaahịa nke na-eṅomi ogige nne na nna bụ ihe ịma aka amata, yana nkwenye dabere na HRMS nke ihe nrụpụta stapled emebibeghị bụ ihe amamihe dị na ya tupu ịme usoro MRM oge niile..

Atụmatụ njikọ

Peptide - njikọ ọgwụ, peptide-polymer conjugates, na peptide-carrier conjugates niile na-anọchite anya ngalaba sara mbara ebe a na-ejikọta mgbanwe ọrụ na peptide nwere njikọ dị iche iche e mere iji dị ndụ ma ọ bụ kewaa na gburugburu ebe obibi akọwapụtara.. Maka ngwa nnyefe ọnụ, Nhazi njikọ na-ekpebi ma ma ihe arụrụ arụ ahụ erutela epithelium intestinal yana ihe na-eme njikọ na ụgwọ ọrụ n'oge njem..

Conjugates nwere ike ihie echere ịhapụ peptide na-arụ ọrụ n'ime obere eriri afọ na-ewebata usoro metabolic kpachaara anya.. Na nzọụkwụ ga-ji analytically - ihe umu na-tọhapụrụ, kedu ọnụego, n'okpuru ihe luminal pH na enzyme ọnọdụ, na ihe mbinye aka nyocha nke iberi enwetara dị ka. Njikọ ndị kwụsiri ike emebere iji lanarị n'ụzọ GI na itinye uche ha na-emebi emebi na-eche ihe ịma aka dị iche ihu: na-egosi na nrụpụta zuru ezu, ọ bụghị ngwaahịa mmebi, bụ ụdị na-emepụta akara pharmacodynamic.

Mgbanwe ọnụ ọnụ - Mmeri kacha mfe bụkwa ihe siri ike ịlele

N-terminal acetylation na C-terminal amidation so na atụmatụ peptide stabilization nke a na-ejikarị eme ihe kpọmkwem n'ihi na ha na-akwụwa aka ọtọ.. Site na iji otu acetyl dochie amine n'efu na N-terminus na ịtụgharị C-terminal carboxyl ka ọ bụrụ amide., A na-ekpochapụ ma saịtị njirimara exopeptidase. Mkpụrụ ndụ ihe na-esi na ya pụta abụghịzi mkpụrụ maka aminopeptidases ma ọ bụ carboxypeptidases, nke na-aza maka ntakịrị ntakịrị nke mmebi peptide luminal.

Ọrụ mgbanwe C-terminal na N-ọnụ mgbanwe ọrụ so na mmemme nyocha na-enyocha nkwụsi ike GI, kpomkwem n'ihi na nkwụsi ike nkwalite n'ihe metụtara njikọ mgbagwoju dị elu. A na-ejikọta mgbanwe njedebe njedebe na usoro ndị ọzọ - peptide cyclized nwere ike na-ebukwa ọkpụkpụ azụ N-methylated amide ma ọ bụ ihe fọdụrụnụ nke fluorinated iji belata polarity - na-eme ka ha bụrụ akụkụ modular karịa atụmatụ kwụ ọtọ..

Kedu ihe nyocha gị kwesịrị ijikwa: Ọdịiche dị n'etiti ọdụ ụgbọ mmiri na-agbanweghị agbanwe na ọdụ acetylated ma ọ bụ amidated dị ntakịrị - 42.011 Na maka acetylation, 0.984 Da maka amidation. N'ime ngwá ọrụ dị ala, ụdị gbanwegharịrị na agbanwebeghị nwere ike ọ gaghị edozi. Karia nka, deamidation ma ọ bụ artifactual acetylation nwere ike ime n'oge njikwa ihe nlele ma ọ bụ ionization electrospray., na-emepụta akara n'azụ na-egbochi ọnụọgụ nke ọnọdụ mgbanwe echere. Maka ọmụmụ nkwụsi ike GI na-enyocha akụkụ dị nta nke peptide adịchaghị agbanwe agbanwe ka oge na-aga, A ga-akwadorịrị nyocha ahụ kpọmkwem megide ụdị emebi emebi kwekọrọ, ọ bụghị naanị megide ndabere matrix. Usoro oghere gụnyere nne na nna emezigharịrị ka achọrọ n'oge nkwado.

Termini na-emetụtakwa omume njide na mgbagha HPLC. C-terminus amidated na-abawanye hydrophobicity metụtara acid efu, na-emetụta ma njigide chromatographic yana ọnụọgụ nkebi peptide na ụdị mmiri GI. A ghaghị tụọ mmetụta ndị a, echeghị, mgbe ị na-atụgharị ntụgharị atụmatụ mgbanwe ọnụ n'usoro ọhụrụ.

Arụmọrụ Bioanalytical Bụ Nsogbu Mgbanwe akọwapụtara

N'ofe klaasị mgbanwe, ụkpụrụ na-agbanwe agbanwe na-apụta: mgbanwe nhazi nke na-eme ka nkwụsi ike GI gbanwee na-agbanwekwa omume nyocha nke peptide n'ụzọ chọrọ mgbanwe-kpọmkwem mmepe usoro.. Usoro LC-MS/MS nke emepụtara maka peptides na-agbanwebeghị agaghị ebufe ya nke ọma na cyclized., lipidated, stapled, ma ọ bụ analọk emezigharịrị na njedebe na-enweghị ọrụ nkwado gbadoro anya na mgbama mgbanwe ndị akọwapụtara.

Nke Ntuziaka EMA na mmepe na imepụta peptides sịntetik na-achọ ka njirimara nyocha nke ihe ọgwụ peptide sịntetik na-ekwu maka oke molekụla, nkwenye usoro amino acid, na ịdị ọcha gbasara ụdị mkpụrụ ndụ a kapịrị ọnụ echere maka ojiji. Maka peptides gbanwetụrụ, nke a pụtara na ngwungwu njirimara ga-amata ọdịiche nke ihe arụrụ arụrụ site na ụdị nwere njikọ chiri anya - ụdị mgbanaka mepere emepe, ụdị deacylated, ụdị deamidated - ọ bụghị naanị site na adịghị ọcha n'ozuzu.

Tebụlụ dị n'okpuru na-achịkọta isi ihe ịma aka bioanalytical nke klaasị mgbanwe ọ bụla webatara yana nzaghachi mmepe kacha nta akwadoro tupu itinye akwụkwọ na ọmụmụ GI PK.:

Peptide PEGylation ejiri dị ka atụmatụ kwụsie ike na mmemme ọnụ na-egosi ọnọdụ nyocha na-achọsi ike. Agbụ PEG na-emepụta nkesa nke ụdị mkpụrụ ndụ - PEG 2000 ya na N = 45 ikwugharị nkeji, ọmụmaatụ, na-emepụta envelopu ion polymeric kama ịka oke - nke na-eme ka ọnụọgụgụ na nyocha ịdị ọcha.. Ọmụmụ na-eji nke 2026 Ihe omumu ihe omumu ihe omumu nke CRS nke anọ dị ka akụkụ ntụaka achọpụtala na uru nnyefe ọnụ nke PEGylation dabere na nha ma nwee ike ibelata mmịnye eriri afọ n'elu oke molecular PEG., na-agbakwụnye mgbanwe imewe ọzọ nke njirimara nyocha ga-agbasorịrị.

Nke Nyochaa atụmatụ PMC ADME mebie ihe ịma aka a nke ọma: lipidization na usoro mgbanwe ndị metụtara ya na-eme ka profaịlụ kwụsie ike GI, mana otu ihe ahụ physicochemical nke na-enyere peptide aka ịlanarị lumen nwere ike ime ka arụmọrụ mmịpụta na nzaghachi ionization dị na matriks nyocha., na-achọ nkwado doro anya karia iche na mbufe usoro.

Ihe Nke a Pụtara maka Nkọwapụta Synthesis Gị

Mkpebi itinye nke ọ bụla n'ime klaasị mgbanwe ndị a n'ime mmemme peptide ọnụ na-emepụta nkọwapụta nke ala nke a ga-akọwarịrị na njikọta.. Mgbanwe a ga-adịrịrị na regiochemistry akọwapụtara ma wepụta nke ọma maka ọrụ nyocha na-esote. Otu peptide cyclic ewepụtara ya na macrolactamization na-ezughị ezu, peptide lipidated nwere heterogeneous fatty acid regiochemistry, ma ọ bụ analọgụ emezigharịrị na njedebe nke nwere mkpuchi na-ezughị ezu ga-emepụta arịa nyocha nke enweghị ike iche na ezigbo nkwụsi ike na nkwụsi ike GI..

Nke a pụtara na nhazi na atụmatụ nyocha abụghị usoro usoro - ha bụ ihe mgbochi yiri nke a ga-ejikọta ọnụ.. Nkọwapụta ịdị ọcha kacha nta a na-anabata maka peptide nyocha nke nnyefe ọnụ bụ nke a na-ekpebi site na ihe nyocha nkwụsi ike nke ala nwere ike ịkpa oke., ọ bụghị naanị site na ihe njikọ nwere ike nweta. Mmekọrịta adịghị ọcha na mgbanwe ezubere n'okpuru ọnọdụ GI assay matrix bụ nsogbu dị njọ karịa otu adịghị ọcha ahụ achọpụtara nke ọma na ọsọ ọsọ ịdị ọcha HPLC kwụ ọtọ..

Ịkọwapụta njirisi nnabata nnabata maka ogige nyocha nke nnyefe ọnụ - mkpụrụ mgbanwe, nkwenye regiochemistry, profaịlụ adịghị ọcha kpọmkwem mgbanwe, na mgbochi - chọrọ ikike ndị na-ere ahịa nke gbasara ma kemịkalụ organic na njirimara nyocha. Mmemme na MOL Mgbanwe na-arụ ọrụ na ndị chọrọ ime peptide gbanwetụrụ nwere ike ịrịọ maka ntule ike ọrụ nka nke na-ekwu maka ụzọ njikọ., mgbanwe mkpụrụ atụmanya, na QC njirimara usoro maka kpọmkwem ewu na-atụle.

MOL Mgbanwe bụ njikọ peptide na ndị na-eweta ọrụ mgbanwe. Edemede a na-egosipụta akwụkwọ agụmakwụkwọ na akwụkwọ nchịkwa ebipụtara na e kwesịghị ịgụ ya dị ka nkwupụta ụlọ ọgwụ. Mgbanwe MOL nwere mmasị azụmahịa na ọrụ mgbanwe peptide zoro aka na akụkọ a.